Elevance Health, Inc. vs Johnson & Johnson — Stock Comparison
Elevance Health, Inc. (ELV) and Johnson & Johnson (JNJ) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Elevance Health, Inc. narrowly edges Johnson & Johnson on Q·Score (6.6 vs 6.1 out of 10), led by Growth (6.8 vs 4.3) and Valuation (7 vs 6.3). Johnson & Johnson scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for ELV (+8.3%) than for JNJ (+6.1%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Consistently beats earnings estimates (4/4 quarters).
70% of 23 covering analysts have a positive rating.
⚠ earnings contracting 96% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
ELV vs JNJ: which stock scores better overall?
Based on Q·Score, Elevance Health, Inc. (ELV) scores 6.6/10 versus Johnson & Johnson (JNJ) at 6.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: ELV or JNJ?
Elevance Health, Inc. (ELV) scores higher on Growth (6.8/10 vs 4.3/10). Elevance Health, Inc. reports revenue growth (1.4% YoY) while Johnson & Johnson reports (5.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is ELV or JNJ more attractively valued?
Elevance Health, Inc. (ELV) scores higher on Valuation (7/10 vs 6.3/10). ELV trades at 14.7× P/E versus JNJ at 22.7×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about ELV vs JNJ?
There are 21 analysts covering ELV with a consensus price target of $479.62, and 22 analysts covering JNJ with a consensus target of $279.41. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: ELV or JNJ?
Johnson & Johnson (JNJ) scores higher on Quality (6.2/10 vs 5.6/10). Net profit margin: ELV at 2.5%, JNJ at 16.2%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: ELV or JNJ?
Elevance Health, Inc. (ELV) scores higher on Financial Health (7/10 vs 6.5/10). Market beta: ELV at N/A, JNJ at 0.21. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of ELV and JNJ?
Elevance Health, Inc. (ELV) has a market capitalisation of $96.0B, while Johnson & Johnson (JNJ) has a market cap of $634.1B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do ELV or JNJ pay dividends?
ELV pays a dividend yield of 1.55%, while JNJ pays a dividend yield of 2.00%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →